• Protocol A6131002: A Randomized, double blind, placebo-controlled study of Xanax XR in the treatment of adolescents with a primary diagnosis of Panic Disorder.
  • Protocol A 6131004: An open label study to asses the safety and tolerance of Xanax XR in the treatment of adolescents with panic disorder or anxiety with panic attacks.
  • Protocol A6131007: A Randomized, double blind, placebo-controlled study of continuation treatment with Xanax XR in the treatment of adolescents with a primary diagnosis of Panic Disorder.